Endometritis

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
1
AzithromycinPhase 41 trial
Active Trials
NCT01721616WithdrawnEst. Nov 2014
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Azithromycin and standard of careN/A1 trial
Active Trials
NCT01235546Completed2,013Est. Dec 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City TherapeuticsAzithromycin
Mission TherapeuticsAzithromycin and standard of care

Clinical Trials (2)

Total enrollment: 2,013 patients across 2 trials

Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis

Start: Nov 2012Est. completion: Nov 2014
Phase 4Withdrawn
NCT01235546Mission TherapeuticsAzithromycin and standard of care

Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection

Start: May 2011Est. completion: Dec 20152,013 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space